TEVA PHARMA (Israel) Buy Hold or Sell Recommendation

TEVA -- Israel Stock  

ILS 3,444  146.00  4.07%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding TEVA PHARMA IND is 'Cautious Hold'. Macroaxis provides TEVA PHARMA buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TEVA positions. The advice algorithm takes into account all of TEVA PHARMA IND available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from TEVA buy-and-hold prospective. Also please take a look at TEVA PHARMA Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell TEVA PHARMABuy TEVA PHARMA
Cautious Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon TEVA PHARMA IND has a mean deviation of 3.7, semi deviation of 3.81, standard deviation of 5.24, variance of 27.48, downside variance of 18.82 and semi variance of 14.49
Macroaxis provides recommendation on TEVA PHARMA IND to complement and cross-verify current analyst consensus on TEVA PHARMA IND. Our buy or sell recommendation engine determines the firm potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure TEVA PHARMA IND is not overpriced, please validate all TEVA PHARMA fundamentals including its Cash and Equivalents, Total Debt and the relationship between Net Income and Cash per Share .

TEVA PHARMA Trading Alerts and Improvement Suggestions

TEVA PHARMA IND appears to be very risky and stock price may revert if volatility continues
TEVA PHARMA IND has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has accumulated 27.48 B in total debt with debt to equity ratio (D/E) of 184.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. TEVA PHARMA IND has Current Ratio of 0.87 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported revenue of 17.45 B. Net Loss for the year was (4.05 B) with profit before overhead, payroll, taxes, and interest of 8.3 B.
Latest headline from www.washingtonpost.com: Prescription opioids destroyed families. Now, victims worry addiction stigma may keep them from getting justice. - The Washington Post

TEVA PHARMA current analysts recommendations

Target Median Price26.00
Target Mean Price26.00
Target High Price26.00
Number Of Analyst Opinions1
Target Low Price26.00

TEVA PHARMA Returns Distribution Density

Mean Return0.46Value At Risk7.01
Potential Upside11.10Standard Deviation5.24
 Return Density 
      Distribution 

TEVA PHARMA Greeks

α
Alpha over DOW
=0.35
β
Beta against DOW=1.63
σ
Overall volatility
=4.20
Ir
Information ratio =0.07

TEVA PHARMA Volatility Alert

TEVA PHARMA IND shows above average downside volatility of 4.34 for selected time horizon. We advise investors to further inspect TEVA PHARMA IND to make sure all market timing and asset allocation strategies are consistent with estimation about TEVA PHARMA future alpha.
    
 Better Than Average     
    
 Worse Than Average Compare TEVA PHARMA to competition

TEVA PHARMA Fundamental Vs Peers

FundamentalsTEVA PHARMAPeer Average
Return On Equity(25.36) (0.31) 
Return On Asset2.73 (0.14) 
Profit Margin(22.88) (1.27) 
Operating Margin15.30 (5.51) 
Current Valuation66.73 B16.62 B
Shares Outstanding1.09 B571.82 M
Price to Earning(773.90) 28.72 
Price to Book283.28 9.51 
Price to Sales2.24 11.42 
Revenue17.45 B9.43 B
Gross Profit8.3 B27.38 B
EBITDA4.36 B3.9 B
Net Income(4.05 B)570.98 M
Cash and Equivalents1.24 B2.7 B
Cash per Share1.14 5.01 
Total Debt27.48 B5.32 B
Debt to Equity184.10 48.70 
Current Ratio0.89 2.16 
Book Value Per Share12.63 1.93 K
Cash Flow from Operations577 M971.22 M
Earnings Per Share(3.77) 3.12 
Price to Earnings To Growth0.50 4.89 
Number of Employees42.53 K18.84 K
Beta1.74-0.15
Market Capitalization39.06 B19.03 B
Total Asset54.26 B29.47 B
Retained Earnings14.99 B9.33 B
Working Capital5.39 B1.48 B
Current Asset18.4 B9.34 B
Current Liabilities13.01 B7.9 B
Z Score0.68.72
Five Year Return2.96
Last Dividend Paid8.5
Search macroaxis.com